Conference - The future of ARVs in Africa
WELCOME
On behalf of the Southern African HIV Clinicians Society (SAHCS) and the Conference Organising Committee, it is our pleasure to invite you to the 3rd SAHCS Long-Acting HIV Treatment and Prevention Conference: ‘The future of antiretrovirals in Africa: Long-acting agents and beyond’.
The conference will take place on Tuesday, 15 September 2026 at the Maslow Hotel, Sandton, Johannesburg, South Africa.
This conference has grown from strength to strength, highlighting the need for a meeting for healthcare professionals focussed on long-acting HIV treatment and prevention. It will review the latest research in the field, provide a platform for discussions around guidelines and real-world implementation of long-acting agents, and will include clinically practical content such as how to administer long-acting injectables, managing missed injections, long pharmacologic tails and resistance risk, drug–drug interactions, and more.
This full-day CPD-accredited conference will provide attendees with up-to-date knowledge and clinical skills for patient treatment, care and support in the context of long-acting antiretrovirals.
We look forward to seeing you in Johannesburg!
Warm regards,
Dr Sheetal Kassim and Ms Rutendo Bothma, Conference Co-Chairs
Dr Ndiviwe Mphothulo, SAHCS President
REGISTRATION
- Early Bird Registration Fee R1,250 including VAT. (Early Bird rate is applicable if registered and paid by 15 May 2026)
- Standard Registration Fee R1,450 including VAT. (Standard rate applies from 16 May 2026)
Registration Includes
Access to all Conference sessions
Tea / coffee breaks and lunch
Parking
Registration Payment Terms & Conditions apply as detailed on the online registration form.
PROGRAMME
Program outline:
Tuesday, 15 September 2026
07:30 Arrival, registration and refreshments
08:30 Conference sessions
10:30 Tea / coffee break
11:00 Conference sessions
13:00 Lunch break
13:50 Conference sessions
15:20 Tea / coffee break
15:45 Conference sessions
17:15 Conference closing
CONFERENCE CHAIRS
 |
Dr Sheetal Kassim is a clinician–scientist and Clinical Research Site Leader at the Desmond Tutu Health Foundation in Cape Town, with extensive experience leading phase 1–3 HIV, TB and COVID-19 clinical trials. She has played a leading role in advancing long-acting injectable HIV treatment and prevention in Africa, serving as Principal and co Investigator on key studies. Her focus is generating high-quality, community-centred evidence to support real-world implementation. |
 |
Ms Rutendo Bothma is a public health specialist with over ten years’ experience in clinical trials, implementation research, and HIV prevention and treatment programming in South Africa, including leadership experience at Wits RHI. She currently serves as a Technical Advisor to the National Department of Health, supporting the national rollout of DMPA-SC as part of expanding access to contraceptive options. Her work focuses on translating evidence into policy and practice, strengthening differentiated service delivery models, and advancing equitable access to long-acting prevention and treatment strategies for priority populations. |
EXHIBITION / SPONSORSHIP
Contact SAHCS today to explore tailored marketing and sponsorship options that will elevate your presence at the 3rd SAHCS Long-Acting HIV Treatment and Prevention Conference: ‘The future of antiretrovirals in Africa: Long-acting agents and beyond’.
Telephone: +27(0)11 728 7365 | Email: janice@sahivcs.org
VENUE
146 Rivonia Rd, Sandton, Johannesburg, 2146, South Africa
The Maslow is located in Sandton's financial district, only a few minutes away from the Sandton Gautrain station, Sandton City mall and Nelson Mandela Square.
CONTACT US
If you have any questions, please do not hesitate to contact the Conference Manager, Janice Candlish, at janice@sahivcs.org or +27(0)11 728 7365.